Sanofi selects Bioclinca’s Onpoint as enterprise CTMS

Monday, October 1, 2012 02:15 PM

Pharmaceutical company Sanofi has selected global provider of clinical trial management services BioClinica’s OnPoint as the company’s standard clinical trial management system (CTMS). With this decision, Sanofi plans to utilize OnPoint CTMS for all clinical trial management activity.

“BioClinica is extremely proud that Sanofi has chosen OnPoint CTMS,” said Mark Weinstein, CEO of BioClinica. “We look forward to helping fulfill the long-term vision of Sanofi through the use of embedded and transformational applications. This is further evidence that our eClinical solutions are not only leading from a technology perspective, but that our people, products and services are some of the best in the industry.”

BioClinica’s OnPoint CTMS helps sponsors centralize and share trial data. OnPoint’s Office-Smart design maximizes Sanofi’s existing investment in Microsoft technologies by letting users access, update and report on clinical trial data from within the familiar environment of Microsoft Office and SharePoint. Using SharePoint as a collaborative portal, OnPoint’s web services integration with other trial management products provides an end-to-end trial management solution. This approach lessons the financial impact of trial management, greatly enhances user adoption and helps avoid the pitfalls of outdated, legacy CTMS products.

“Providing an end-to-end clinical development platform that unifies the best available solutions is an important part of BioClinica’s approach to trial management,” said Peter Benton, president of eClinical solutions, BioClinica. “OnPoint’s ability to exchange information across multiple systems, including Sanofi’s choice of eTMF (electronic trial master file), makes OnPoint the best choice for clinical trial management and demonstrates why BioClinica is the innovation leader in eClinical products.”

Share:          
CWWeekly

March 30

Icon, Carnegie Mellon partner to research ways to improve study patients' understanding of Informed Consent

Veeva launches OpenKey, partner program to unlock difficult access to, restrictions on customer reference data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs